Karen A. Dawes - 11 May 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
11 May 2021
Net transactions value
-$2,102
Form type
4
Filing time
13 May 2021, 17:01:29 UTC
Next filing
17 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $48,300 +15,000 +15% $3.22 115,734 11 May 2021 Direct
transaction RGEN Common Stock Sale $50,402 -285 -0.25% $176.85 115,449 11 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 -15,000 -100% $0.000000* 0 11 May 2021 Common Stock 15,000 $3.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $176.85 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.73 to $176.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 This option is fully vested and exercisable.

Remarks:

Exhibit 24.1: Power of Attorney